Trials / Completed
CompletedNCT04698707
Role of Supermicrosurgical LVA for Lower Limb Lymphedema
The Role of Supermicrosurgical Lymphaticovenous Anastomosis for Lower Limb Lymphedema - A Retrospective Cohort Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 131 (actual)
- Sponsor
- Chang Gung Memorial Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
Vascularized lymph node flap transfer (VLNT) was believed to be the treatment of choice for moderate-to-severe lymphedema. Recent publications have supported the use of supermicrosurgical lymphaticovenous anastomosis (LVA) for treating severe lymphedema. This study hypothesizes whether LVA can be performed on post-VLNT patients seeking further improvement.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Vascularized lymph node flap transfer | Patients who have received VLNT as their primary treatment but with minimal improvement |
| OTHER | Patients without prior lymphedema surgery | Patients without prior lymphedema surgery |
Timeline
- Start date
- 2020-08-28
- Primary completion
- 2020-10-05
- Completion
- 2020-11-19
- First posted
- 2021-01-07
- Last updated
- 2021-01-07
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04698707. Inclusion in this directory is not an endorsement.